Laboratory Activity 10: Osmotic Fragility Test (Oft)
Laboratory Activity 10: Osmotic Fragility Test (Oft)
Laboratory Activity 10: Osmotic Fragility Test (Oft)
OSMOTIC FRAGILITY
TEST (OFT)
1
Hereditary Erythrocyte
Membrane Abnormalities
2
HEREDITARY SPHEROCYTOSIS
• Blood film
• Microspherocytes
• Pathophysiology
• Spectrin
• Actin
• Protein 4.1
3
HEREDITARY SPHEROCYTOSIS
4
HEREDITARY SPHEROCYTOSIS
5
HEREDITARY SPHEROCYTOSIS
6
HEREDITARY SPHEROCYTOSIS
• Aplastic crisis
• pancytopenia develops due to lack of
marrow cell production
• Chronic bone marrow hyperplasia
• Skeletal abnormalities
7
HEREDITARY SPHEROCYTOSIS
• Laboratory Findings and Correlation with
Disease
• Complete Blood Count
• Peripheral Blood Film
• Bone Marrow
• Special Hematology Tests
• Chemistry
8
Complete Blood Count
• Hemoglobin:
• Adults: above 10g/dL
• Infants and young children: lower levels (8-11g/dL)
• MCV:
• 77-87fL
• MCHC:
• increased in ½-2/3 of patients
• Reticulocytes:
• 5%-20%
• Increased in aplastic crisis
• RDW normal to increased
9
Peripheral Blood Film
10
Bone Marrow
11
Chemistry
12
Special Hematology Tests
13
Diagnosis of Hereditary
Spherocytosis
MOST FREQUENTLY • CBC with MCHC
REQUIRED • Peripheral blood film
examination
• Osmotic fragility test
• Reticulocyte count
OCCASIONALLY REQUIRED • Autohemolysis
• Direct antiglobulin test
• Serum unconjugated
(indirect) bilirubin
• Serum haptoglobin
RARELY REQUIRED • Bone marrow examination
14
OSMOTIC FRAGILITY TEST
• reflects the shape of RBCs
• decreased surface area-to-
volume ratio
• spherocytes have a limited
capacity to expand in hypotonic
solutions
• increased osmotic fragility.
• hypochromic or flatter cells
• decreased osmotic fragility.
15
OSMOTIC FRAGILITY TEST
• Specimen requirement
• Fresh heparinized blood
• 15-20 mL of defibrinated whole blood
• Anticoagulants containing oxalates
should NOT be used
• Reagents
• Saline concentrations
• Laboratory made
• Prepackaged
16
OSMOTIC FRAGILITY TEST
• Procedure
• Absorbance:
• Measured spectrophotometrically at 540
17
OSMOTIC FRAGILITY TEST
18
OSMOTIC FRAGILITY TEST
19
OSMOTIC FRAGILITY TEST
20
INCUBATED OSMOTIC
FRAGILITY
21
Sources of Error
22
Sources of Error
23
Sources of Error
24
DIRECT ANTIGLOBULIN TEST
25
Treatment of HS
• Splenectomy
• prevents complications such as aplastic
crisis and gallbladder disease
• should be delayed as long as possible
• Splenectomized patients have a normal
life expectancy.
26
GROUP OUTPUT
27